Author/Creator: Regadera, A. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Regadera, A.

1. Impact of DNMT3A and IDH1/IDH2 Mutations on Treatment Response with Azacitidine in Myeloid Neoplasms. (April 2017)

Authors:: Martín, I.; Navarro, B.; Such, E.; Calabuig, M.; Villamón, E.; Sanz, G.; Cervera, J.; Amat, P.; García, F.; Serrano, A.; Mora, E.; Regadera, A.; Pérez, A.; Solano, C.; Tormo, M.
Journal:: Leukemia research
Issue:: Volume 55(2017)Supplement 1
Page Start:: S157
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Interpretation of NGS Results for Clinical Practice in Myelodysplastic Syndromes. (April 2017)

Authors:: Mora, E.; Such, E.; Regadera, A.; Díaz, A.; Martínez, F.; Hernani, R.; Carretero, C.; Osorio, J.; Guinot, M.; Saus, A.; Vicente, A.; Senent, L.; Ibáñez, M.; Cordón, L.; Sempere, A.; Cervera, J.; Sanz, M.A.; Sanz, G.
Journal:: Leukemia research
Issue:: Volume 55(2017)Supplement 1
Page Start:: S110
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Long Tracking Analysis About Management of Azacitidine in Patients with Myelodysplastic Syndrome. (April 2017)

Authors:: Molero, A.; Mora, E.; Ávila, F.; Revelles, M.; Merchan, B.; Regadera, A.; Alonso, S.; Montoro, J.; Martin, M.; Benlloch, L.; Garcia, R.; Bernal, T.; Sanz, G.; Valcárcel, D.
Journal:: Leukemia research
Issue:: Volume 55(2017)Supplement 1
Page Start:: S66
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗